140 related articles for article (PubMed ID: 1356621)
1. Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines.
Collart FR; Chubb CB; Mirkin BL; Huberman E
Cancer Res; 1992 Oct; 52(20):5826-8. PubMed ID: 1356621
[TBL] [Abstract][Full Text] [Related]
2. Regulation and role of inosine-5'-monophosphate dehydrogenase in cell replication, malignant transformation, and differentiation.
Huberman E; Glesne D; Collart F
Adv Exp Med Biol; 1994; 370():741-6. PubMed ID: 7661012
[No Abstract] [Full Text] [Related]
3. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.
Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS
Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721
[TBL] [Abstract][Full Text] [Related]
4. Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines.
Konno Y; Natsumeda Y; Nagai M; Yamaji Y; Ohno S; Suzuki K; Weber G
J Biol Chem; 1991 Jan; 266(1):506-9. PubMed ID: 1670768
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions.
Liu Y; Riley LB; Bohn SA; Boice JA; Stadler PB; Sherley JL
J Cell Physiol; 1998 Nov; 177(2):364-76. PubMed ID: 9766533
[TBL] [Abstract][Full Text] [Related]
6. Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase.
Barnes BJ; Izydore RA; Eakin AE; Hall IH
J Pharmacol Exp Ther; 2001 Aug; 298(2):790-6. PubMed ID: 11454943
[TBL] [Abstract][Full Text] [Related]
7. Inosine monophosphate dehydrogenase and myeloid cell maturation.
Knight RD; Mangum J; Lucas DL; Cooney DA; Khan EC; Wright DG
Blood; 1987 Feb; 69(2):634-9. PubMed ID: 2879579
[TBL] [Abstract][Full Text] [Related]
8. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
9. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells.
Nagai M; Natsumeda Y; Weber G
Cancer Res; 1992 Jan; 52(2):258-61. PubMed ID: 1345808
[TBL] [Abstract][Full Text] [Related]
10. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
Wright DG; Boosalis M; Malek K; Waraska K
Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
[TBL] [Abstract][Full Text] [Related]
11. Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines.
Williams K; Chubb C; Huberman E; Giometti CS
Electrophoresis; 1998 Feb; 19(2):333-43. PubMed ID: 9548300
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters.
Gu JJ; Spychala J; Mitchell BS
J Biol Chem; 1997 Feb; 272(7):4458-66. PubMed ID: 9020170
[TBL] [Abstract][Full Text] [Related]
13. Cloning and sequence of the human type II IMP dehydrogenase gene.
Glesne DA; Huberman E
Biochem Biophys Res Commun; 1994 Nov; 205(1):537-44. PubMed ID: 7999076
[TBL] [Abstract][Full Text] [Related]
14. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression.
Dayton JS; Lindsten T; Thompson CB; Mitchell BS
J Immunol; 1994 Feb; 152(3):984-91. PubMed ID: 7905505
[TBL] [Abstract][Full Text] [Related]
15. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma.
Kofuji S; Hirayama A; Eberhardt AO; Kawaguchi R; Sugiura Y; Sampetrean O; Ikeda Y; Warren M; Sakamoto N; Kitahara S; Yoshino H; Yamashita D; Sumita K; Wolfe K; Lange L; Ikeda S; Shimada H; Minami N; Malhotra A; Morioka S; Ban Y; Asano M; Flanary VL; Ramkissoon A; Chow LML; Kiyokawa J; Mashimo T; Lucey G; Mareninov S; Ozawa T; Onishi N; Okumura K; Terakawa J; Daikoku T; Wise-Draper T; Majd N; Kofuji K; Sasaki M; Mori M; Kanemura Y; Smith EP; Anastasiou D; Wakimoto H; Holland EC; Yong WH; Horbinski C; Nakano I; DeBerardinis RJ; Bachoo RM; Mischel PS; Yasui W; Suematsu M; Saya H; Soga T; Grummt I; Bierhoff H; Sasaki AT
Nat Cell Biol; 2019 Aug; 21(8):1003-1014. PubMed ID: 31371825
[TBL] [Abstract][Full Text] [Related]
16. Gene amplification and dual point mutations of mouse IMP dehydrogenase associated with cellular resistance to mycophenolic acid.
Lightfoot T; Snyder FF
Biochim Biophys Acta; 1994 Mar; 1217(2):156-62. PubMed ID: 7906545
[TBL] [Abstract][Full Text] [Related]
17. Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation.
Liu Y; Bohn SA; Sherley JL
Mol Biol Cell; 1998 Jan; 9(1):15-28. PubMed ID: 9436988
[TBL] [Abstract][Full Text] [Related]
18. Inosine monophosphate dehydrogenase expression: transcriptional regulation of the type I and type II genes.
Zimmermann A; Gu JJ; Spychala J; Mitchell BS
Adv Enzyme Regul; 1996; 36():75-84. PubMed ID: 8869741
[TBL] [Abstract][Full Text] [Related]
19. Inosine 5'-monophosphate dehydrogenase as a chemotherapeutic target.
Franklin TJ; Edwards G; Hedge P
Adv Exp Med Biol; 1994; 370():155-60. PubMed ID: 7660881
[No Abstract] [Full Text] [Related]
20. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
